GL1X · GenesisL1 explorer

Research workbench

FGFR1 in complex with dovitinib

Analyse FGFR1 in complex with dovitinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5A46
Type
protein
Length
586 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, pfeiffer syndrome)…
UniProt
D3DSX2
Ligands
38O, SO4
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, pfeiffer syndrome), isoform CRA_Bprotein28938% helix, 15% strandD3DSX2
BFibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, pfeiffer syndrome), isoform CRA_Bprotein29738% helix, 15% strandD3DSX2

Ligands and binding sites

  • 38O · 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17590.730.7981empty
27910.720.7764EDO, 38O, SO4
36490.690.7757EDO, 38O, SO4
4600.270.7317empty

Interfaces

1 interface between chains.

  • A–B · 486 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 5A46 · FGFR1 in complex with dovitinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.